Dr. Afshan K. Alvi, MD

Dr. Alvi practices at University of Virginia Physicians Group in Zion Crossroads, Virginia.

Dr. Alvi's NPI, 1104158567, was assigned on February 9, 2010. Dr. Alvi holds Virginia license 0101279204.

Dr. Alvi's primary practice is University of Virginia Physicians Group, at 1015 Spring Creek Pkwy, Zion Crossroads, VA 22942 in Orange County. The practice phone is (434) 295-1000.

Dr. Alvi's primary practice is University of Virginia Physicians Group in Zion Crossroads, Virginia. Dr. Alvi is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Alvi to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alvi practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Alvi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Alvi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Alvi's licenses on file in 2 states: Virginia and New Jersey.

CMS data shows 1,886 Medicare services from Dr. Alvi across 10 procedure codes in 2024, for 833 Medicare patients. Medicare paid $70,974 for them. Every service was in an office.

CMS counts 833 Medicare patients who saw Dr. Alvi in 2024. The largest group is 75 to 84, with 353 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alvi's median patient age at 65, with 51% women.

In 2024, Dr. Alvi wrote 2,393 Medicare Part D claims for 482 patients. 86% of them were for generic drugs. CMS names the drug for 2,162 of them, across 35 drugs with 11 or more claims each, at $280,724 in total drug cost. In 2023, CMS named 393 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Alvi for performance year 2024, reported as part of a group. Dr. Alvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Alvi, published from 2013 to 2019. Dr. Alvi's most frequent co-authors are Elizabeth Jane Chuang, MD, Ayesha Salahuddin, MD and Daniel M. Spevack, MD.

CMS Open Payments shows 13 general payments to Dr. Alvi from 9 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $192.